Abstract
The whole-cell tight seal recording technique was used to investigate location of benzothiazepine binding site of the cardiac L-type Ca2+ channel. For this we utilized a permanently charged compound, SQ 32.428, out of a series of benzazepine drugs which have been characterized as competitive inhibitors of diltiazem binding. The non-permanently charged derivative SQ 32.910 was initially tested to electrophysiologically establish Ca2+ antagonistic properties of benzazepines. Upon extracellular application, either compound was able to completely block Ca2+ currents. At a stimulating frequency of 0.2 Hz IC50 concentrations of SQ 32.910 and SQ 32.428 were determined as 35 nM and 15 μM, respectively. Intracellular application of SQ 32.428 was then compared to control experiments in the absence of drug. Initially, adequate drug dialysis was confirmed with 100 μM D890, which produced a progressive inhibition of Ca2+ currents within 10 min after whole-cell access. In contrast, internal application of 100 μM SQ 32.428 did not change time-course of Ca2+ currents compared to control run-down. These results show that the benzazepine/benzothiazepine binding domain of the cardiac L-type Ca2+ channel is accessible only from the extracellular side and therefore suggest an extracellular location on the α 1-subunit of the Ca2+ channel protein.
References
Catterall WA and Striessnig J (1992) Receptor sites for Ca2+ channel antagonists. TIPS 13: 256–262
Glossmann H and Striessnig J (1988) Calcium channels. Vitamins and Hormones 44: 155–328
Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ (1981) Improved patch-clamp technique for high resolution current recording from cell and cell-free membrane patches. Pflügers Arch 391: 85–100
Hescheler J, Pelzer D, Trube G and Trautwein W (1982) Does the organic calcium channel blocker D600 act from the inside or outside on the cardiac cell membrane. Pflügers Arch 393: 287–291
Kass RS, Arena JP and Chin S (1991) Block of L-type calcium channels by charged dihydropyridines. J Gen Physiol 98: 63–76
Kimball SD, Floyd DM, Jagabandhu D, Hunt JT, Krapcho J, Ronnyak G, Duft KJ, Lee VG, Moquin RV, Turk CF, Hedberg SA, Moreland S, Brittain RJ, McMullen DM, Normanidin DE and Cucinotta GG (1992) Benzazepinone calcium channel blockers 4. Structure-Activity overview and intracellular binding site. J Med Chem 35: 780–793
Leblanc N and Hume JR (1989) D600 block of L-type Ca2+ channel in vascular smooth muscle cells: comparison with permanently charged derivative, D890. Am J Physiol 257: C689-C695
Lee KS and Tsien RW (1983) Mechanism of calcium channel blockade by verapamil, D600, diltiazem and nitrendipine in single dialysed heart cells. Nature 302: 790–794
Regulla S, Schneider T, Nastainczyk W, Meyer HE and Hofmann F (1991) Identification of the site of interaction of the dihydropyridine channel blockers nitrendipine and azidopine with the calcium channel α 1 subunit. EMBO J 10: 45–49
Romanin C, Grösswagen P and Schindler H (1991) Calpastatin and nucleotides stabilize cardiac calcium channel activity in excised patches. Pflügers Arch 418: 86–92
Striessnig J, Glossmann H and Catterall WA (1990) Identification of a phenylalkylamine binding region within the α 1 subunit of skeletal muscle Ca2+ channels. Proc Natl Acad Sci USA 87: 9108–9112
Striessnig J, Murphy BJ and Catterall WA (1991) Dihydropyridine receptor of L-type Ca2+ channel: Identification of binding domains for [3H](+)-PN200-110 and [3H]azidopine within the α 1 subunit. Proc Natl Acad Sci USA 88: 10769–10773
Hering S, Savchenko A, Strübing C, Lakitsch M and Striessnig J (1993) Extracellular localization of the benzothiazepine binding domain of L-type Ca2+ channels. Mol Pharmacol in press
Strübing C, Hering S and Glossmann H (1993) Evidence for an external location of the dihydropyridine agonist receptor site on smooth muscle and skeletal muscle calcium channels. Br J Pharmacol 108: 884–891
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Seydl, K., Kimball, D., Schindler, H. et al. The benzazepine/benzothiazepine binding domain of the cardiac L-type Ca2+ channel is accessible only from the extracellular side. Pflügers Arch. 424, 552–554 (1993). https://doi.org/10.1007/BF00374922
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00374922